Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
Marchi E, Alinari L, Tani M, Stefoni V, Pimpinelli N, Berti E, Pagano L, Bernengo MG, Zaja F, Rupoli S, Pileri S, Baccarani M, Zinzani PL.
Marchi E, et al. Among authors: tani m.
Cancer. 2005 Dec 1;104(11):2437-41. doi: 10.1002/cncr.21449.
Cancer. 2005.
PMID: 16216001
Free article.
Clinical Trial.